Objective: Restrictive leaflet tethering resulting from regional left ventricular (LV) contractile injury causes ischemic mitral regurgitation (MR). We hypothesized that 3-dimensional LV topographic mapping by MRI-based multiparametric strain analysis could characterize the regional contractile injury patterns that differentiate ischemic coronary artery disease patients who have ischemic MR from those who do not.
Contractile injury in the papillary regions distinguishes patients with ischemic mitral regurgitation from those without mitral regurgitation.
Central Message
MRI-based 3D topographic mapping of regional LV contractile injury patterns differentiates patients with ischemic MR from patients without ischemic MR.
Perspective
Because mitral leaflet tethering from regional left ventricular contractile injury is the root cause of ischemic mitral regurgitation, characterization of associated contractile injury distribution may affect management. The imaging and analytical capabilities necessary to perform a high-resolution topographic 3-dimensional mapping of regional contractile injury have only recently become clinically available.
See Editorial Commentary page 159.
Ischemic mitral regurgitation (MR) is characterized by a structurally normal mitral valve (MV) with regurgitation due to left ventricular (LV) dysfunction. 1 The primary root cause of ischemic MR is restrictive leaflet tethering resulting from regional LV ischemic contractile injury. 2 Displacement of the papillary muscles, especially the posteromedial papillary muscle, leads to restrictive tethering and deformation of the MV leaflets with impaired leaflet coaptation and resulting regurgitation. 3, 4 The regional distribution of the ischemic contractile injury is key in determining the occurrence, severity, and exact mechanism of subsequent MR in patients with coronary artery disease (CAD) and myocardial infarction. 1, 5 Until recently, the standard of care in the surgical treatment of ischemic MR has been revascularization combined with undersized mitral ring annuloplasty. Unfortunately, recent randomized trial data have demonstrated recurrence of at least moderate MR in up to 59% of patients undergoing MV repair by 2 years of follow-up, in comparison to only 4% of patients undergoing MV replacement. 6, 7 Although these results suggest that the long-term outcomes of MV replacement may be superior to MV repair, the higher perioperative mortality, sacrifice of the native valve apparatus, potential long-term prosthesis deterioration, and need for anticoagulation associated with MV replacement cannot be overlooked. 2, [8] [9] [10] Given the considerable disadvantages of MV replacement, the remaining 40% of patients who may do well with MV repair should not be abandoned to valve replacement for a lack of clinically applicable prognostic metrics.
Because recurrent or persistent MR after annuloplasty repair is likely to occur by the same mechanism as primary ischemic MR (ie, leaflet tethering by ischemia-induced regional contractile injury and remodeling), regional contractile injury distribution patterns have potential to predict repair failure in ischemic MR. Whereas several echocardiographic features have been shown to correlate with MR recurrence after MV repair, including measures of leaflet and chordal geometry [11] [12] [13] [14] and measures of LV remodeling, [15] [16] [17] [18] these are all indirect surrogates of the regional ventricular contractile dysfunction responsible for ischemic MR. Logically, our first goal must be the full characterization of the ischemia-induced contractile injury distribution patterns that are associated with preoperative ischemic MR, because variants of these prognostic patterns have the highest likelihood of providing metrics to predict recurrent or persistent MR after repair. Although speckle-tracking echocardiography can supply some degree of quantitative measurements of global and regional contractile function, cardiac MRI is widely regarded as the most accurate imaging modality for quantitative assessment of LV function. 19, 20 A high-resolution, highly quantitative characterization of regional contractile function is necessary to uncover the complexities of the contractile injury distribution that causes ischemic MR. Only recently has a quantitative description of truly 3-dimensional (3D) regional LV contractile function by regional 3D strain calculation from MRI-derived LV displacement data become clinically available. We have demonstrated the high reliability of MRI-based multiparametric strain topographic mapping in the quantification and localization of regional LV contractile injury in patients with CAD. 21 As a first step in evaluating the clinical application of this technology to ischemic MV disease, we sought to fully map the associated distribution patterns of regional contractile injury in patients with ischemic MR. We hypothesized that topographic strain mapping of regional LV contractile function could characterize the regional contractile injury patterns that differentiate ischemic CAD patients who have MR from those who do not.
METHODS

Study Participants
The Institutional Review Board of Washington University School of Medicine approved this study, and all subjects gave written informed consent. One hundred forty-six total study participants were enrolled in the study and underwent cardiac MRI with radiofrequency tissue tagging. One hundred of these participants were normal, healthy volunteers with no historical, physical, or clinical evidence of heart disease who contributed complete strain parameter information to a normal human strain database. The remaining 46 participants were patients with ischemic CAD, 10 of whom had ischemic MR and 36 of whom had ischemic CAD without MR. CAD was defined as ! 1 lesion of ! 70% stenosis on coronary angiography as interpreted by an independent cardiac catheterization laboratory blinded to study results. MR was defined as moderate (! 2) or greater MR as determined by an independent echocardiography laboratory blinded to study results. Restricted leaflet motion was the cause of the MR in all 10 patients with ischemic MR.
Cardiac MRI
All imaging studies were carried out using a 1.5T scanner (Siemens, Erlangen, Germany). Short-axis grid-tagged MR images were acquired in a stack starting at the level of the MV and extending to the apex of the LV, whereas long-axis line-tagged images were acquired in 4 radially oriented planes intersecting at the approximate center of the LV cavity (Figure 1, A) . In each imaging plane, a spatial modulation of magnetization radiofrequency tissue-tagging preparation was applied, followed by a 2-dimensional balanced steady-state free precession cine image acquisition. 22, 23 This process creates markers on the myocardium that deform with the tissue, which allows for quantification of wall motion. Typical imaging parameters were repetition time 32.4 ms, echo time 1.52 ms, field of view 350 3 350 mm, flip angle 20 , tag spacing 8 mm, and slice thickness 8 mm.
Strain Analysis
Strain measurements were obtained for all study participants using an established and validated method developed at our institution. [24] [25] [26] [27] Clinical validation of this methodology has demonstrated resistance to interobserver variability. 28, 29 Endocardial and epicardial wall boundaries were manually identified on each of the images. Tag lines were tracked
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on each of the images semiautomatically utilizing an active contour approach.
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3D displacements were computed for systole from the intramyocardial intersection points of the 3 tag surfaces. The end-diastolic wall boundaries were used to create a finite element model of the LV. Using the anterior and posterior insertion points of the right ventricle to the LV as landmarks, a standardized 18-element mesh was created for each model (Figure 1, B) . A least squares fitting of the displacement data provided the strain measurements for this study. Circumferential strain and longitudinal strain were computed over a standardized grid of 15,300 points for the entire LV (Table E1 ). The finite element software package StressCheck (ESRD, Inc, St Louis, Mo) was used to obtain the strain measurements for this study.
Normalization and Multiparametric Strain Analysis
A normal human strain database was constructed using strain measurements from the 100 normal participants. At each LV grid point and for each strain parameter, measurements from the normal participants were used to generate a normal mean and standard deviation (SD) at that particular point. This database of normal strain values allows for patientspecific, point-specific, and parameter-specific comparisons with z score generation. A z score is a statistical measurement that relates an individual value to the mean of a group of values, and represents the number of SDs by which the patient strain parameter value varies from the normal mean value. For example, if a patient's circumferential strain parameter has a z score of 1.57 at a particular point, this means that his or her contractile function in the area of that grid point is 1.57 SDs worse than the normal average.
For the 46 test patients with CAD with or without MR, z scores for both circumferential and longitudinal strain were calculated at every LV grid point by reference to the normal human strain database. The z scores for the 2 strain parameters were then averaged to generate a single multiparametric strain z score at each point. Because 2 strain parameters were normalized at each of 15,300 LV grid points for each patient study, each patient's LV color contour topographic mapping of multiparametric strain values represents a total of 30,600 individual database comparisons (Figure 1, C) . Worse contractile function results in more positive z scores.
Subregional LV Strain Analysis
Mean multiparametric strain z scores were calculated for the 18 LV subregions, which included the basilar, mid, and apical levels of the anterior, anterolateral, posterolateral, posterior, posteroseptal, and anteroseptal regions. Subregions were classified as either papillary muscle-related (basilar and mid levels of anterolateral, posterolateral, and posterior) and nonpapillary muscle-related (all other subregions).
Mean multiparametric strain z scores for the papillary and nonpapillary muscle subregions were compared between the ischemic MR and ischemic no-MR groups.
Statistical Analysis
Continuous variables were expressed as means AE SD and were compared using 2-sample t tests. Categorical variables were expressed as frequencies and percentages, and were compared using c 2 analysis. Average multiparametric strain z scores in the papillary and nonpapillary muscle-related subregions were compared between the ischemic MR and ischemic no-MR groups using a mixed analysis of variance analysis, with post hoc analysis for between-group effects by 2-sample t tests. The Shapiro-Wilks test was used to assess the normality of the data, and Levene's test was used to test the equality of error variances. Data analyses were performed using SPSS 23.0 statistical software (IBM-SPSS Inc, Armonk, NY). Composite 3D LV color contour multiparametric strain Values are presented as n, mean AE standard deviation, or % (n/N).
maps were created using Matlab computing software (MathWorks, Inc, Natick, Mass).
RESULTS
Clinical characteristics of the study test patients are shown in Table 1 and echocardiographic and cardiac catheterization characteristics are shown in Table 2 . There were no significant differences between the ischemic MR and ischemic no-MR patient groups in the prevalence of evaluated medical comorbidities, the distribution of coronary artery lesions, or echocardiographic evaluation of LV ejection fraction or regional ventricular dysfunction.
The analysis of variance revealed a significant main effect for the LV subregion (F[1, 44] ¼ 7.877; P ¼ .007; observed power ¼ 0.784), indicating that z scores in the papillary regions were greater than those in the nonpapillary regions without regard to the presence of MR. This analysis also indicated a significant interaction between the presence of MR and the LV subregion (F[1,44] ¼ 6.588; P ¼ .014, observed power ¼ 0.706). On subregional analysis, strain values for the papillary muscle-related subregions were significantly higher in the ischemic MR group compared with ischemic no-MR group (1.91 AE 1.13 vs 1.20 AE 1.01; P < .001) (Figure 2 ). In contrast, strain values in the nonpapillary muscle-related subregions were not different between the ischemic MR and ischemic no-MR groups (1.31 AE 1.04 vs 1.20 AE 1.03; P ¼ .301) (Figure 2 ). Global z scores were not found to be significantly different between the MR and no MR groups (F[1,44] ¼ 2.049; P ¼ .159).
The availability of multiparametric strain data at each of 15,300 points in a uniform, standardized LV grid for every patient in each of the 2 groups enables a unique visual presentation of each group's mean regional strain data. Composite 3D LV color contour maps displaying the topographic distribution of the average, normalized multiparametric strain for each group are shown in Figure 3 . Each color map demonstrates the regional normalized contractile injury distribution of an average patient with ischemic no-MR (Figure 3, A) or with ischemic MR (Figure 3, B) . The images represent 4-quadrant endocardial views from each group's composite, highresolution, rotatable 3D LV model. Full videos of the rotating contour maps are available in Video 1. The group composite maps highlight the differences in regional contractile injury distribution between the ischemic no-MR and ischemic MR groups, and clearly illustrate a greater degree of contractile injury in the papillary muscle-related subregions for ischemic MR patients.
Further, because both study groups have average z score values for each strain parameter at each LV grid point, this methodology also uniquely allows an intuitive visual display of the differences in normalized regional contractile injury distribution, obtained by subtracting the 15,300 point-specific average z scores between the 2 patient subgroups. Thus, by simply subtracting the average multiparametric strain metric z scores at each LV grid point, we can see, in the resulting composite subtraction map, the precise contractile injury distribution that causes ischemic MR. The composite 3D LV subtraction map is shown in Figure 4 and in Video 2. The composite subtraction map highlights the more severe normalized contractile injury in the ischemic MR group and the localization of this difference to the papillary muscle-related subregions, most notably in the region of the posteromedial papillary muscle. A lesser but notable difference in normalized contractile injury was associated with the anterolateral papillary muscle. In the red regions of the 3D LV map, the ischemic MR group demonstrates > 1 SD worse contractile injury than the ischemic no-MR group. The blue color represents regions in which there is no difference in contractile function between the 2 groups.
DISCUSSION
Ischemic MR is caused by regional ventricular contractile injury-based papillary muscle displacement resulting in restrictive leaflet tethering. 1 Leaflet tethering, changes in chordal geometry, and all of the other structural metrics that have been associated with ischemic MR occur as a consequence of regional contractile abnormalities and are therefore secondary surrogates of the contractile injury This study used MRI-based multiparametric strain analysis to topographically map normalized regional LV contractile injury in ischemic CAD patients with and without MR. Multiparametric strain analysis provides an By averaging multiparametric strain z scores in all patients in each group at every left ventricular (LV) grid point, a topographic map of average regional normalized contractile injury distribution for each group is uniquely visualized. These images represent the normalized contractile injury distribution of an average patient from each group. Shown are 4-quadrant endocardial views of the composite 3-dimensional LV color contour maps of the ischemic no mitral regurgitation group (A) and ischemic mitral regurgitation group (B). The color scale represents a 2.5 standard deviation range. Black ovals represent approximate papillary muscle insertion sites. PS, Posteroseptal; P, posterior; PL, posterolateral; A, anterior; AL, anterolateral; AS, anteroseptal.
objective, highly quantified measure of myocardial contractile function and viability. 21, 30, 31 Higher multiparametric strain z score values are reflective of worse contractile function, with strain z scores > 1.5 accurately identifying regions of nonviable myocardium. 31 We have recently demonstrated the reliability of this technology in comparison to other gold standard clinical metrics for evaluating the heterogeneity of ventricular dysfunction in patients with CAD and previous infarction. 21 In this study, multiparametric strain analysis demonstrated worse global contractile function in the ischemic MR group. This difference in contractile function was primarily localized to the papillary muscle-related LV subregions, because the ischemic MR group had markedly worse contractile injury in the basilar and mid levels of the anterolateral, posterolateral, and posterior subregions. Average strain z scores in the region of the posteromedial papillary muscle were almost 2 SDs worse than normal in the ischemic MR group (Figure 3) , and exceeded the ischemic no-MR group by > 1 SD (Figure 4 ). This is a very large difference and demonstrates the severity of the contractile injury localized to these regions in the ischemia patients who manifest MR.
Multiparametric strain analysis of regional LV contractile function was therefore able to characterize the regional contractile injury patterns that differentiate ischemic CAD patients who have MR from those who do not. A specific and discernible topographic pattern of regional LV contractile injury is seen in patients with ischemic MR that is easily differentiated from the injury pattern seen in ischemic patients with no MR. An advantage of presenting the group average subtraction data in a visual format is the ability to visually associate the profound group subtraction differences in normalized regional contractile injury with the 2 mitral papillary muscle insertion sites (Figure 4) . Ventricular function in the nonpapillary muscle-related subregions was not different between the ischemic MR and ischemic no-MR groups. These findings are consistent with the known pathophysiology of MR, in that regional ventricular dysfunction affecting the papillary muscles leads to tethering, deformation, and insufficiency of the valve leaflets. 1 Although these findings support the potential clinical applicability of this technology in the detailed characterization of ventricular function in patients with ischemic CAD and resulting MV disease, this study is admittedly a step removed from predicting MR recurrence after MV repair. Given that nearly 60% of patients undergoing MV repair for ischemic MR experience recurrence by 2 years of follow-up, 7 reliable metrics for predicting repair failure are needed. Multiple echocardiographic predictors of repair failure have been proposed [11] [12] [13] [14] [15] [16] [17] [18] ; however, in a recent follow-up analysis to the Cardiothoracic Surgical Trials Network study on severe ischemic MR, no measures of MV leaflet tethering or geometry were significantly associated with MR recurrence. The presence of basal aneurysm or dyskinesis was strongly associated with recurrent MR and was included in a pilot multivariable predictive model with moderate performance for prediction of recurrent MR. 18 The potential for reverse remodeling and recovery of regional ventricular function is a key determinant of the success of MV repair, as illustrated by the interesting finding that greater LV reverse remodeling occurs in patients who undergo MV repair and do not experience recurrence, compared with patients undergoing MV replacement. 32 In patients with positive LV reverse remodeling after MV repair for ischemic MR (reduction in LV end-systolic volume index ! 15%), freedom from recurrent MR was > 90%. 33 Similarly, patients in the Cardiothoracic Surgical Trials Network trial who underwent MV repair without recurrence had lower LV end-systolic volume indices at follow-up than those who experienced recurrence. 7, 10 These data suggest that MV repair is more likely to be successful in patients with potential for reverse ventricular remodeling.
The ability to objectively and reliably identify patients with potential for regional LV contractile recovery, especially in the papillary muscle-related regions, is a unique strength of MRI-based multiparametric strain analysis and may provide insight into the decision regarding VIDEO 1. By averaging multiparametric strain z scores in all patients in each group at every left ventricle (LV) grid point, a 3-dimensional (3D), rotatable topographic LV map of average regional normalized contractile injury distribution for each group can be uniquely visualized. This video shows rotating views of the 2 group maps representing the normalized contractile injury distribution of an average patient from each group. Shown here are rotating composite 3D LV color contour maps of the ischemic mitral regurgitation (left) and ischemic no mitral regurgitation (right) groups. The color scale represents a 2.5 standard deviation range. Black ovals represent approximate papillary muscle insertion sites. PL, Posterolateral; AL, anterolateral; A, anterior; AS, anteroseptal; PS, posteroseptal; P, posterior. Video available at: http://www. jtcvsonline.org/article/S0022-5223(16)31679-8/addons. MV repair versus replacement. Our previous work has demonstrated the ability of this technology to reliably characterize regional LV myocardial viability in ischemic cardiomyopathy 31 and to predict regional contractile recovery after aortic valve replacement. 34 In previous studies we have demonstrated that a multiparametric strain z score regional average > 1.52 is highly associated with irreversible regional myocardial injury, detecting nonviability with >90% sensitivity and specificity. 31 Minimal contractile recovery potential is expected in subregions demonstrating such severe impairment of normalized contractile function. We are particularly encouraged that this contractile metric may have the potential to uncover the complex topographic injury distribution patterns that correlate with repair failure in ischemic MR, which is the focus of ongoing work in our laboratory.
Limitations of the proposed clinical application of MRI-based multiparametric stain analysis include the expense of MRI and the time requirement for postprocessing of myocardial strain data. However, with advances in MR image acquisition technology and moreautomated data analysis, our current scan times are < 30 minutes, with associated data analysis requiring < 20 minutes. Another potential limitation of this methodology, common to other measurements of regional myocardial contractility, is that it can quantify only myocardial strain. Ventricular contractility is embodied in strain (ie, how well the wall is moving), stress (ie, how much force the wall is exerting), and time (ie, how quickly the wall is moving). Ideally, stress and strain would be concurrently quantified. Unfortunately, current methods for accurately quantifying regional myocardial stress in the clinical setting are severely limited.
CONCLUSIONS
The highly quantified characterization of LV contractile injury distribution patterns by MRI-based multiparametric strain analysis demonstrated clear and significant FIGURE 4 . The overarching goal of this study was to visually demonstrate the differences in normalized contractile injury topographic distribution between those patients with coronary artery disease who have ischemic mitral regurgitation (MR) and those who do not. Shown here are 4-quadrant endocardial views of a subtraction 3-dimensional left ventricular (LV) color contour map demonstrating differences in LV strain distribution between ischemic MR and ischemic no-MR groups. This unique visualization is only possible because of the availability of group average multiparametric strain z score values at each of 15,300 points in a uniform, standardized grid in both patient groups, which can therefore be subtracted from each other. These 4 views of this composite LV mapping of the subtraction differences between the groups demonstrate the normalized contractile injury distribution that is responsible for the occurrence of MR in this ischemic coronary artery disease patient population. The color scale represents a 1.2 standard deviation range in subtraction differences between the 2 patient groups. Red regions represent > 1 full standard deviation increase in contractile injury in the ischemic MR group, whereas blue areas represent no difference between the 2 groups. Black ovals represent approximate papillary muscle insertion sites. PS, Posteroseptal; P, posterior; PL, posterolateral; A, anterior; AL, anterolateral; AS, anteroseptal. differences between those ischemic CAD patients who have ischemic MR and those who do not. Further, this methodology has unique capabilities in regard to the intuitive presentation of study group summary data in 3D, rotatable, LV color contour, normalized, multiparametric strain maps. Because all regional contractile function is already normalized to a population of healthy volunteers (ie, normal human strain database), the interpretation of summated raw strain data results is provided. Specifically, color contouring based on regional SDs from the normal mean clearly delineates severely injured regions on easily interpreted 3D LV maps. These maps additionally allow a visual summation of the results of this investigation by the simple subtraction of the 2 study group maps. This subtraction color contoured LV map demonstrates the summated differences between those ischemic CAD patients who have ischemic MR and those who do not. This methodology uniquely allows an intuitive visual demonstration of the overarching goal of this investigation that is not available with any other clinically applicable modality: A color contour LV subtraction map representing the normalized regional contractile injury distribution pattern in ischemic CAD patients that results in ischemic MR.
Webcast
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VIDEO 2. The overarching goal of this study was to visually demonstrate the topographic differences in normalized contractile injury distribution between those ischemic coronary artery disease patients who have ischemic mitral regurgitation (MR) and those who do not. Shown here is a video of a rotating subtraction 3-dimensonal left ventricle (LV) color contour map demonstrating differences in LV strain distribution between ischemic MR and ischemic no-MR groups. This unique visualization is only possible because of the availability of group average multiparametric strain z score values at each of 15,300 points in a uniform, standardized grid in both patient groups (with and without ischemic MR), which can therefore be subtracted from each other. This rotating composite LV map of the subtraction differences between the groups demonstrates the normalized contractile injury distribution that is responsible for the occurrence of MR in this ischemic patient population. The color scale represents a 1.2 standard deviation range in subtraction differences between the 2 patient groups. Red regions represent > 1 full standard deviation increase in contractile injury in the ischemic MR group, whereas blue areas represent no difference between the 2 groups. Black ovals represent approximate papillary muscle insertion sites. AL, Anterolateral; A, anterior; AS, anteroseptal; PS, posteroseptal; P, posterior; PL, posterolateral. Video available at: http://www.jtcvsonline.org/article/ S0022-5223(16)31679-8/addons.
Key Words: ischemic mitral regurgitation, myocardial mechanics, regional contractile injury, strain mapping Discussion Dr Tomasz Timek (Grand Rapids, Mich). Congratulations on an excellent study and equally excellent presentation. Ischemic mitral regurgitation (MR) continues to frustrate us, and although we now have 2 randomized trials, I do not think we are any closer to a clear answer on how we are supposed to treat these patients.
The key finding of your study is the difference in strain relationships in the myocardial segments that subtend the papillary muscles. This has previously been shown in both animal and clinical work with echocardiography.
My first question relates to the preoperative echo. What was the nature of the preoperative MR jet in patients who had MR and did you see any distinct myocardial regional wall abnormalities in those patients? Dr Lancaster. All the patients were patients who were evaluated for surgery and were referred to us with routine clinical echocardiograms. All the patients had moderate (ie, 2+) or greater MR. In terms of the specific characterization of the MR jets, we did not analyze that in this study or compare the regional wall abnormalities by echocardiography with the findings by MR.
Dr Timek. Could you theoretically pick up these differences with echocardiography?
Dr Lancaster. We did not compare these specific patients, but in previous studies we compared magnetic resonance imaging (MRI)-based strain mapping with other methodologies for assessment of regional contractile function and found a very good correlation, for example, with Q waves on electrocardiogram or regional echocardiographic abnormalities. So I expect that we would also see a strong correlation between echocardiography and MR for the patients in this study.
Dr Timek. So this gets into my next question. You showed a z score of almost 2 between the patients who had regurgitation and those who did not, in the subpapillary regions, and, as you mentioned, that essentially means nonviability. Could you draw similar conclusions by simply doing a clinical MRI study for viability or a nuclear study? What is the incremental advantage of your technology?
Dr Lancaster. The big advantages of our technology over other methods for viability assessment are the objective and quantitative nature as well as the ability to produce very high resolution visual displays of the data. As I am sure you are aware, other techniques like positron emission tomography and single-photon emission computed tomography as well as dobutamine echocardiography provide qualitative assessment of viability, which is dependent on the observer, and also provide lower resolution and poorer transmural assessment of viability. All of those things are provided by MRI-based strain mapping in better detail.
Other methods for assessing viability by MRI include dobutamine MRI and delayed gadolinium enhancement. Those also are more subjective and less quantitative than this method. So the objectivity and the quantitativeness are the real advantage.
Dr Timek. Your study elegantly confirms, as I already mentioned, the now accumulating and vast evidence that in ischemic MR, the central lesion is really in the subpapillary region. So looking into the future, how does this help us identify the patients who should have mitral replacement, mitral repair, or-for those with moderate MR-just coronary bypass grafting?
Dr Lancaster. As you alluded to, in the recent Cardiothoracic Surgical Trials Network randomized trials, almost 60% of patients who underwent mitral repair failed by 2 years of follow-up. An interesting conclusion from those studies is when you look at the patients who had repair but did not recur, there were substantial reductions in left ventricular end systolic volume index, demonstrating that they had contractile recovery. The patients who either had mitral valve replacement or had mitral valve repair and recurrence had less evidence of ventricular remodeling.
The key going forward is the ability to delineate viability, especially in the posterior wall and in relation to the posteromedial papillary muscles. That is the real strength of this analysis. We have demonstrated in the past its ability to assess myocardial viability and contractile recovery after surgical intervention, and the ability to precisely localize that to the regions that contribute to ischemic MR I think will help. The direction that we are going is to use this tool to predict the likelihood of success after mitral valve repair.
Dr Timek. Thank you. 
